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Normal implantation is critical for a successful pregnancy. Briefly, the implantation in the endometrium occurs around 6-7 days after the conception and normally the human blastocyst implants in the upper portion of the uterus. It starts with apposition of the blastocyst to the endometrium with subsequent invasion into the endometrium. The trophoblast on the anchoring villi invades through the endometrium into the inner 1/3 of myometrium and maternal spiral arteries ( Fig. 1 : gestational sac) (1) . Implantation abnormalities lead to a group of disorders encompassing several entities: placental shape abnormalities, velamentous cord insertion, maternal vascular malperfusion due to deficient remodeling of the maternal spiral arteries; abnormally located placentation and morbidly adherent placenta (1, 2) . This section will focus on the abnormally located placentation, which includes placenta previa, low-lying/ marginal placenta and cesarean scar implantation, and the morbidly adherent placentation (1, 2) .
ETIOPATHOGENESIS
Abnormality of decidualization either by trauma or deficiency of decidua, as in cases of placenta previa implanting in the lower uterine segment or cesarean scar, is the common factor in the etiology of abnormal placentation. The pathogenesis seems to involve an abnormal interaction between the decidua and the invasive extravillous trophoblast, leading to a failure of maternal tissues to restrain the invading trophoblast (3-6). Multiple hypotheses have been raised to explain this abnormality. One of them is that antiinvasive factors, that are antagonist to matrix metalloproteinases or are activator of tissue inhibitor of metalloproteinases secreted by the decidua, are deficient in areas of decreased decidualization (7) . Another possibility, is an imbalance in the paracrine/autocrine regulation between the deficient decidualized endometrium and the invasive trophoblasts (8) .
RISK FACTORS
Risk factors include any factors that may lead to damage and scaring of the endometrium. Previous cesarean delivery or uterine surgery, including prior dilation and curettage and myomectomies, spontaneous or induced abortion, and history of prior pregnancy with abnormal placentation are the most important (9) (10) (11) (12) . In the primigravida, endometriosis and assisted conception have been associated with abnormal placentation (13, 14) . An increased number of prior cesarean deliveries is also a risk factor due to the multiple uterine scars (15) .
IMAGING
ensuring that a multidisciplinary team is prepared for the delivery (12, 16) . Transabdominal ultrasound is the primary technique used to rule-out abnormal placentation; however, there are limitations to this technique and false positive results may occur (17) . The addition of color Doppler to the ultrasonography examination increases the sensitivity for the diagnosis of abnormal placentation (17) . Ultrasound and magnetic resonance imaging (MRI) appear to have similar sensitivity for the diagnosis of abnormal placentation. In cases of posterior accreta, MRI is more useful than the ultrasound examination (17) . By imaging, the diagnosis of abnormal placentation is characterized by the disappearance of the normal subplacental clear space adjacent to the uteroplacental interface, extreme thinning of the underlying myometrium, discontinuity of low signal zone in the gap between bladder and the uterus, irregularities of the bladder wall and vascular changes within the placenta. Useful signs on MRI includes placental bulge with distorted uterine outline, uterine serosal hypervascularity, dark intraplacental bands of fibrin deposition extending from the myometrium interface appearing as low-signal intensity on T2-weighted images and cervical varicosities (18, 19) . However, in spite of the advance in imaging technique, the depth of invasion and accurate differential diagnosis between accreta, increta and percreta relies on the pathological examination of the post-partum hysterectomy (20) .
TYPES OF ABNORMAL PLACENTATION
Low-lying marginal placenta Definition Low-lying placenta is a placenta that ends 2 cm of the internal cervical os but do not cover it (21) .
Most commonly the placenta implantation occurs in the uterine fundus, followed by implantation in the anterior wall and posterior wall (22) . Low-lying placentas are most frequently diagnosed ultrasonographically in the second trimester and more often, they resolve by the third trimester. However, when persistent, they are a risk factor for postpartum hemorrhage (23, 24) . Different from placenta previa, vaginal delivery is possible with low-lying placentas (25) .
Placenta previa
Definition Placenta previa is defined as a placenta with complete or partial obstruction of the internal cervical os; therefore, being "previous" to the delivering fetus. Placenta previa is a major cause of third trimester bleeding and has been associated with severe maternal morbidity including hemorrhage requiring blood transfusion, disseminated intravascular coagulation and emergency hysterectomy (26) . In the fetus, acute and massive bleeding from placenta previa has been associated with fetal brain damage and cerebral palsy (27) . There is an increased occurrence of placenta previa in women with advanced maternal age, multiparity, smoking, drug abuse, prior cesarean delivery, and placenta previa in prior pregnancy (28, 29) . Among those, advanced maternal age and prior cesarean delivery are the main risk factors and the recent increased incidence of these factors is likely responsible for temporal increased incidence of placenta previa (30) . Due to its location in the lower segment of the uterus, a place that has increased vascularity and decreased contractility which are predisposing factors for bleeding, the diagnosis of placenta previa warrants multidisciplinary management which may sometimes result in a cesarean hysterectomy (16, (31) (32) (33) (34) (35) . In cases in which the mother wishes to preserve fertility, more conservative approaches have been used; however, a 20% failure rate has been described associated with severe complication (31) . Gross examination of the hysterectomy will show a placenta implanted in the lower uterine segment obstructing the internal cervical OS ( Fig. 2A and  B) . Microscopically, placenta is noted adjacent to endocervical mucosa, and frequently a remote hematoma is present (Fig. 2C) . Placenta previa may be associated with myometrial fibers adherent to the basal plate of a delivered placenta, also known as occult placenta accreta (Fig. 3C and D) .
Cesarean scar implantation
Definition Cesarean scar implantation refers to the placental implantation within the scar of a prior cesarean delivery.
The surgical hysterotomy incision does not heal with complete repair of the myometrium; instead, a thin fibrous scar is formed holding the myometrial fibers together. Within the scar, no decidua is noted leading to morbidly adherent placentas among other complications. Molecules that enhance endometrial receptivity during normal implantation, such as b3 and leukemia-inhibitor factor (LIF), have been shown to be overexpressed in the site of abnormal implantation in a cesarean scar site when compared with the remaining uterine cavity (36) . The placental implantation may occur in a dehiscent scar or a well-healed scar (37) . When the implantation occurs in a dehiscent scar, it has worst prognosis, probably due to the thinning of the myometrium noted in areas of a dehiscent scar (37) . Most often, when diagnosed in the first trimester, cesarean scar pregnancies are treated with methotrexate or dilation and curettage. Expectant management is possible but it is usually associated with increased incidence of hysterectomy due to placental implantation abnormalities or uterine rupture (38, 39) .
Morbidly adherent placenta

Definition
Morbidly adherent placenta is an umbrella term encompassing similar entities with varying degree of severity.
Placenta accreta: defined by the placenta attachment onto the myometrium without intervening decidualized endometrium (2, 20, 40, 41) .
Placenta increta: there is placental invasion into the thinned myometrium and absent decidua.
Placenta percreta: the placental invasion is total extending through the myometrium to the uterine serosa and sometimes into adjacent organs, most frequently the bladder (2, 20, 40, 41) .
Myometrial fibers adherent to the basal plate without intervening decidua or "occult placenta accreta": Refers to the presence of myometrial fibers in the basal plate without intervening decidua in the delivered placenta (Fig. 3) . Invasive trophoblast is present in varying numbers as is the basal Nitabuch fibrinoid layer. These cases may represent a subclinical form of adherent placenta; however, they often have delayed placental delivery, manual removal, or disruption. There is an increased risk for development of clinical apparent placenta accreta in a subsequent pregnancy (42) .
Other histological findings which were significantly more frequently seen in morbidly adherent placentas when compared to controls include basal chronic villitis, chronic lymphoplasmacytic inflammation in the basal plate, villous agglutination, remote retromembranous hemorrhage, subchorionic intervillous thrombi (43, 44) , and chorionic villi extending into myometrial vascular spaces in postpartum hysterectomies. Morbidly adherent placenta is a frequent cause of postpartum hemorrhage, delayed separation or retained placenta, which is defined clinically as placenta expulsion at least 30 minutes after the delivery of the newborn (16, 45) . A multidisciplinary approach to patients diagnosed with morbidly adherent placenta in the prenatal period is desirable and reduces the need for emergency cesarean hysterectomy (16) . Grossly, the hysterectomy shows an enlarged, boggy uterus that when opened reveals a placenta most often located in the lower uterine segment (Fig. 4) . Dilated tortuous vessels are noted in the uterine serosa, marking the site of placental implantation. These vessels are seen in the MRI and are one of the features used in diagnosing morbid adherent placenta (18) . In some cases in which there is total invasion of the myometrium (placenta percreta) one can see the placental tissue protruding through the uterine surface. Microscopically, there is increased thinning of the myometrium depending on the severity of the placental tissue extension into the myometrium (Fig. 5) . No or very patchy decidualized endometrium is seen in between the invasive trophoblast and the myometrium (Fig. 5A ) in placenta accreta. In most cases, Nitabuch fibrinoid will be present as well as a variable amount of invasive trophoblast. In placenta increta (Fig. 5B) , the amount of myometrium is minimal and the scarce invasive extravillous trophoblasts are noted extending into the myometrium. In placenta percreta (Fig. 5C ), no myometrium is noted and the placenta tissue is onto the uterine serosa and sometimes invading adjacent organs, most frequently the bladder. Trophoblast may be seen extending into the serosal tissues, fibrinoid layer is minimal. When in doubt, cytokeratin and vimentin immunohistochemical stains may be useful in distinguishing decidua (vimentin positive) from invasive trophoblast (cytokeratin positive). 
CONCLUSION
The disorders of placental implantation group include many entities which have in common a decreased or absent decidualized endometrium resulting in abnormal implantation and increased placental adhesion. There is an increase in maternal and fetal morbidity and mortality associated with these entities and the treatment most often involves a cesarean hysterectomy. A multidisciplinary approach is the best way to reduce morbidity and mortality.
